XALUD THERAPEUTICS, INC.

Profile

Company Names

XALUD THERAPEUTICS, INC.

Addresses

2120 UNIVERSITY AVENUE, SUITE 532, BERKELEY, CA 94704

200 GARRETT STREET, SUITE S, CHARLOTTESVILLE, VA 22902

Phone Numbers

434-980-8105

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$30,478,983.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-05-18 
$18,178,983.00 
$30,000,001.00 
$11,821,018.00 
Equity 
2
2020-03-06 
$5,000,000.00 
$25,150,000.00 
$20,150,000.00 
Equity 
1
2015-05-27 
$7,300,000.00 
$7,300,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RAYMOND 
 
CHAVEZ 
EXECUTIVE OFFICER, DIRECTOR
XALUD THERAPEUTICS, INC.
STEPHEN 
 
COLLINS 
EXECUTIVE OFFICER, DIRECTOR
MOONTOAST, LLC   |  MOONTOAST, INC.   |  CANTOR REAL ESTATE INCOME + OPPORTUNITY FUND, LLC   |  SPINIFEX PHARMACEUTICALS INC   |  XALUD THERAPEUTICS, INC.   |  MEDIASPECTRUM, INC.   |  WHEAT SELF-STORAGE PARTNERS I, LP   |  OSKA, INC.   |  ENGAGE THERAPEUTICS, INC.   |  PGIM SENIOR LOAN OPPORTUNITIES (LEVERED) I, L.P.   |  PGIM SENIOR LOAN OPPORTUNITIES I CO-INVESTMENT II (FEEDER FUND), LP   |  PGIM SENIOR LOAN OPPORTUNITIES I CO-INVESTMENT II, LP   |  ATOMBEAM TECHNOLOGIES INC.   |  PGIM SENIOR LOAN OPPORTUNITIES (PARALLEL FUND) II, L.P.   |  PGIM SENIOR LOAN OPPORTUNITIES (LEVERED) II, L.P.   |  PGIM SENIOR LOAN OPPORTUNITIES (UNLEVERED) II, L.P.   |  PGIM SENIOR LOAN OPPORTUNITIES (RATED FEEDER FUND) II, L.P.   |  PGIM SENIOR LOAN OPPORTUNITIES II JPY FEEDER FUND, L.P.
JOHN 
 
FORSAYETH 
DIRECTOR
XALUD THERAPEUTICS, INC.
PETER 
 
HEINECKE 
DIRECTOR
XALUD THERAPEUTICS, INC.
PAUL 
B. 
MANNING 
DIRECTOR
DOVA PHARMACEUTICALS, INC.   |  XALUD THERAPEUTICS, INC.   |  ARCHERDX, INC.   |  TAYSHA GENE THERAPIES, INC.   |  LIQUIDIA CORP   |  VERRICA PHARMACEUTICALS INC.
DIEM 
 
NGUYEN 
EXECUTIVE OFFICER, DIRECTOR
EXTEND DEVICE CORP   |  XALUD THERAPEUTICS, INC.   |  VITARA BIOMEDICAL, INC.   |  VERRICA PHARMACEUTICALS INC.
JAYSON 
 
RIEGER 
DIRECTOR
INTREXON CORP   |  VERRICA PHARMACEUTICALS INC.   |  XALUD THERAPEUTICS, INC.
SEAN 
 
STALFORT 
DIRECTOR
VERRICA PHARMACEUTICALS INC.   |  ADVANTAGENE, INC.   |  XALUD THERAPEUTICS, INC.   |  TOLERION, INC.   |  SALIOGEN THERAPEUTICS, INC.   |  TAYSHA GENE THERAPIES, INC.   |  BLUE MARLIN THERAPEUTICS, INC.
LINDA 
 
WATKINS 
DIRECTOR
XALUD THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-06-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-18 
2020-03-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-06 
2015-07-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#